European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 271-275 , March 2009

Lymph nodes in the tail of the breast can be missed in standard axillary dissection

  • R.N. Williams

      Affiliations

    • Leicestershire Breast Unit, Glenfield Hospital, University Hospitals of Leicester, Groby Road, Leicester LE3 9QP, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 116 2563505; fax: +44 116 2563206.
  • ,
  • L. Jones

      Affiliations

    • Department of Pathology, St. Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK
    • Formerly Department of Pathology, Glenfield Hospital, University Hospitals of Leicester.
  • ,
  • A. Stotter

      Affiliations

    • Leicestershire Breast Unit, Glenfield Hospital, University Hospitals of Leicester, Groby Road, Leicester LE3 9QP, UK

,Accepted 26 February 2008.

References 

  1. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer, College of American Pathologists consensus statement 1999. Arch Pathol Lab Med. 1999;124:966–978
  2. Saha S, Farrar WB, Young DC, et al. Variation in axillary node dissection influences the degree of nodal involvement in breast cancer patients. J Surg Oncol. 2000;73:134–137
  3. Stotter A, Chandler T. Breast cancer: outcome of axillary management in 1991. Eur J Surg Oncol. 1999;25:261–264
  4. Carter CL, Allen C, Henson DE. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–187
  5. Ruffin WK, Stacey-Clear A, Younger J, et al. Rationale for routine axillary dissection in carcinoma of breast. J Am Coltrunl Surg. 1995;180:245–251
  6. Haybittle JL, Blamey RW, Elston CW, et al. A prognostic index in primary breast cancer. Br J Cancer. 1982;45:361–366
  7. Galea MH, Blamey RW, Elston CE, et al. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat. 1992;22:207–219
  8. Vinh-Hung V, Verschraegen C, Promish DI, et al. Ratios of involved nodes in early breast cancer. Breast Cancer Res. 2004;6(6):680–688
  9. Petrik DW, McCready DR, Sawka CA, et al. Association between extent of axillary lymph node dissection and patient, tumour, surgeon, and hospital factors in patients with early breast cancer. J Surg Oncol. 2003;82:84–90
  10. Schaapveld M, Otter R, Vries EGE, et al. Variability in axillary lymph node dissection for breast cancer. J Surg Oncol. 2004;87:4–12
  11. Stotter A. Revised prognostic table to guide practitioners advising patients on adjuvant systematic therapy in early breast cancer. Eur J Surg Oncol. 2007;33(10):1211–1212
  12. Salama JK, Heinmann R, Lin F, et al. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have a prognostic significance?. Cancer. 2004;103(4):664–671
  13. Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002;52:277–300
  14. International Union Against Cancer (UICC) . In:  Sobin LH,  Wittekind CH editor. TNM classification of malignant tumours. 6th ed.. New York: Wiley-Liss; 2002;
  15. Association of Breast surgery @ BASO, Royal college of surgeons of England . Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol. 2005;31(Suppl. 1):1–21
  16. Kutiyanawala MA, Sayed M, Stotter A, et al. Staging the axilla in breast cancer: an audit of lymph-node retrieval in one UK regional centre. Eur J Surg Oncol. 1998;24:280–282
  17. Somner JEA, Dixon JMJ, Thomas JSJ. Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status. J Clin Pathol. 2004;57:845–848
  18. Smith JA, Gamez-Araujo JJ, Gallager HS, et al. Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer. 1977;39(2):527–532
  19. Boova RS, Bonanni R, Rosato FE. Patterns of axillary nodal involvement in breast cancer. Predictability of level one dissection. Ann Surg. 1982;196(6):642–644
  20. Veronesi U, Luini A, Galimberti V, et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol. 1990;16(2):127–133
  21. In:  Morris PJ,  Wood WC editor. 2nd ed.. Oxford textbook of surgery. vol. 2:Oxford University Press; 2000;
  22. Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005;28(3):289–294

PII: S0748-7983(08)00082-6

doi: 10.1016/j.ejso.2008.02.012

European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 271-275 , March 2009